BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Nosology
,
Rosiglitazone
,
rs2230926
,
DRD2
,
Metabolism of xenobiotics
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
spike protein human
Summary
General Info
Curated Studies
Most Correlated Studies
Leukemia monocytic THP-1 cells treated with SARS-CoV-2 spike protein
Renal proximal tubule epithelial cells treated with IFNA1, IFNB1, IFNG, IL1B and ruxolitinib
Umbilical cord vein endothelial cells treated with combinations of JQ1 and TNFA
Cervical carcinoma HeLa cells with ribosomal RNA-processing protein RRP40 and cofactor MTR4 siRNAs
Neuroblastoma cell lines treated with THZ1, actinomycin D, MYCN shRNA, or MYCN-overexpression
Explore Curated Studies Results
Literature
Most Relevant Literature
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.
Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics d…
Human SARS CoV-2 spike protein mutations.
Mutations in the receptor-binding domain of human SARS CoV-2 spike protein increases its affinity to…
COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhe…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Sp…
Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COV…
CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)
A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV…
Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ